09/13/2024 | Press release | Archived content
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | September 13, 2024 4:05 P.M. |
Form: | S-3 | |||||
|
Please select the service you want to use:
Smartlinks | Akari Therapeutics plc | News | Crime and Judiciary | Judiciary | Health | Politics and Policy | Economic Policy | Policy and Regulation | Government | National Government | Economic Policy | Subsidies and Government Aid | Company News | Investment Funds | Judiciary | Securities Issuers | Biotechnology and Medical Research Companies | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact